Advisory Committee on the Medical Uses of Isotopes: Meeting Notice

• Published date: 07 March 2024
• Record Number: 2024-04836
• Citation: 89 FR 16590
• Court: Nuclear Regulatory Commission
• Section: Notices

Federal Register, Volume 89 Issue 46 (Thursday, March 7, 2024)

[Federal Register Volume 89, Number 46 (Thursday, March 7, 2024)]
                [Notices]
                [Pages 16590-16591]
                From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
                [FR Doc No: 2024-04836]
                =======================================================================
                -----------------------------------------------------------------------
                NUCLEAR REGULATORY COMMISSION
                Advisory Committee on the Medical Uses of Isotopes: Meeting
                Notice
                AGENCY: U.S. Nuclear Regulatory Commission
                ACTION: Notice of meeting.
                -----------------------------------------------------------------------
                SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) will convene a
                meeting of the Advisory Committee on the Medical Uses of Isotopes
                (ACMUI) on April 8-9, 2024. A sample of agenda items to be discussed
                include: a review of recent medical events; a review of prescription
                error reduction methods; and a review of several NRC draft licensing
                guidance documents for the Eye90 microsphere device, the Akesis Galaxy
                RTi unit, and the LV Liberty Vision Y-90 episcleral brachytherapy
                source. The agenda is subject to change. The current agenda and any
                updates will be available on the ACMUI's Meetings and Related Documents
                web page at https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2024.html or by emailing Ms. L. Armstead at the contact
                information below.
                 Purpose: Discuss issues related to 10 CFR part 35 Medical Use of
                Byproduct Material.
                 Date and Time for Open Sessions: April 8, 2024, from 8:30 a.m. to
                4:30 p.m. and April 9, 2024, from 10 a.m. to 12 p.m. eastern standard
                time.
                 Address for Public Meeting: U.S. Nuclear Regulatory Commission, One
                White Flint North Building (Commissioner's Hearing Room, O1-F16/O1-
                G16), 11555 Rockville Pike, Rockville, Maryland 20852.
                ------------------------------------------------------------------------
                 Date Webinar information (Microsoft teams)
                ------------------------------------------------------------------------
                April 8, 2024................ Link: https://teams.microsoft.com/l/meetup-join/19%3ameeting_NjllNmZkODktZTg3My00MDU0LTk4NzMtNjRhNmJlYmRmNGY 4NzMtNjRhNmJlYmRmNGY 1%40thread.v2/
                 0?context=%7b%22Tid%22%3a%22e8d01475-
                 c3b5-436a-a065-
                 5def4c64f52e%22%2c%22Oid%22%3a%22304f46b
                 f-32c2-4e0f-912c-878db895e74a%22%7d
                 Meeting ID: 257 264 946 630.
                 Passcode: n3TZmR.
                [[Page 16591]]
                
                 Call in number (audio only): +301-576-
                 2978, Silver Spring.
                 Phone Conference ID: 954 210 683#.
                ------------------------------------------------------------------------
                 Public Participation: The meeting will be held in-person and as a
                webinar using Microsoft Teams. Any member of the public who wishes to
                participate in the meeting in person, via Microsoft Teams, or via phone
                should contact Ms. L. Armstead using the information below. Members of
                the public should also monitor the NRC's Public Meeting Schedule at
                https://www.nrc.gov/pmns/mtg for any meeting updates.
                 Contact Information: Ms. L. Armstead, email: [email protected],
                telephone: 301-415-1650.
                Conduct of the Meeting
                 The ACMUI Chair, Hossein Jadvar, M.D., Ph.D., will preside over the
                meeting. Dr. Jadvar will conduct the meeting in a manner that will
                facilitate the orderly conduct of business. The following procedures
                apply to public participation in the meeting:
                 1. Persons who wish to provide a written statement should submit an
                electronic copy to Ms. L. Armstead using the contact information listed
                above. All submittals must be received by the close of business on
                April 2, 2024, and must only pertain to the topics on the agenda.
                 2. Questions and comments from members of the public will be
                permitted during the meeting, at the discretion of the ACMUI Chair.
                 3. The draft transcript and meeting summary will be available on
                ACMUI's website https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2024.html on or about May 24, 2024.
                 4. Persons who require special services, such as those for the
                hearing impaired, should notify Ms. L. Armstead of their planned
                participation.
                 This meeting will be held in accordance with the Atomic Energy Act
                of 1954, as amended (primarily section 161a); the Federal Advisory
                Committee Act (5 U.S.C. app); and the Commission's regulations in title
                10 of the Code of Federal Regulations, part 7.
                 Dated at Rockville, Maryland this 4th day of March, 2024.
                 For the U.S. Nuclear Regulatory Commission.
                Russell E. Chazell,
                Federal Advisory Committee Management Officer.
                [FR Doc. 2024-04836 Filed 3-6-24; 8:45 am]
                BILLING CODE 7590-01-P